Education
About Us
Working with TipRanks
Follow Us
Inmode (INMD)
:INMD
INMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.14 - $19.85
Previous CloseN/A
Volume968.14K
Average Volume (3M)1.11M
Market Cap
$1.04B
Enterprise Value$414.34M
Total Cash (Recent Filing)$510.68M
Total Debt (Recent Filing)$6.10M
Price to Earnings (P/E)6.1
Beta1.30
Next Earnings
Oct 22, 2025EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.47
Shares Outstanding69,558,670
10 Day Avg. Volume1,070,429
30 Day Avg. Volume1,108,114
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.40
Enterprise Value/Revenue1.03
Enterprise Value/Gross Profit1.29
Enterprise Value/Ebitda3.36
Forecast
1Y Price Target
$17.50Price Target Upside16.82% Upside
Rating ConsensusHold
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Consumer DemandA shift toward noninvasive platforms highlights increasing demand for lower-cost procedures, positioning INMD well to capture evolving consumer preferences.
Market StrategyINMD continues to invest in the business and lean into its long-term strategy, working to restructure parts of the sales team to more deeply penetrate market segments.
Product ExpansionINMD is expanding global direct operations and launching new platforms across both noninvasive aesthetics and clinical areas.
Bears Say
Economic ChallengesWaning consumer and provider demand due to inflationary pressures have affected InMode's performance.
Geopolitical RisksGeopolitical risks, including tariff concerns and the situation in Israel, pose additional challenges for InMode.
Revenue GuidanceThe company lowered its FY25 revenue guidance to $365M-$375M from $395M-$405M.
InMode News
INMD FAQ
What was Inmode’s price range in the past 12 months?
Inmode lowest stock price was $13.14 and its highest was $19.85 in the past 12 months.
What is Inmode’s market cap?
Inmode’s market cap is $1.04B.
When is Inmode’s upcoming earnings report date?
Inmode’s upcoming earnings report date is Oct 22, 2025 which is in 44 days.
How were Inmode’s earnings last quarter?
Inmode released its earnings results on Jul 30, 2025. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.411 by $0.059.
Is Inmode overvalued?
According to Wall Street analysts Inmode’s price is currently Undervalued.
Does Inmode pay dividends?
Inmode does not currently pay dividends.
What is Inmode’s EPS estimate?
Inmode’s EPS estimate is 0.34.
How many shares outstanding does Inmode have?
Inmode has 69,558,670 shares outstanding.
What happened to Inmode’s price movement after its last earnings report?
Inmode reported an EPS of $0.47 in its last earnings report, beating expectations of $0.411. Following the earnings report the stock price went down -2.865%.
Which hedge fund is a major shareholder of Inmode?
Currently, no hedge funds are holding shares in INMD
InMode Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$17.50 (16.82% Upside)
$17.50 (16.82% Upside)
Blogger Sentiment
Bullish
INMD Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.5M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.28%
12-Months-Change
Fundamentals
Return on Equity
25.91%
Trailing 12-Months
Asset Growth
-17.62%
Trailing 12-Months
Company Description
Inmode
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
INMD Company Deck
INMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted revenue growth, strong gross margins, and strategic market expansions. However, challenges in the North American market, reduced guidance, and increased operating expenses were noted as significant concerns.View all INMD earnings summariesINMD Stock 12 Month Forecast
Average Price Target
$17.50
▲(16.82% Upside)
Technical Analysis
Ownership Overview
―
Insiders
9.05% Mutual Funds
25.16% Other Institutional Investors
63.15% Public Companies and Individual Investors